Hyperinsulinaemic hypoglycaemia

Hormone and Metabolic Research

Volumn 46, Issue 3, 2014, Pages 157-170

  Arya, V B ^a   Mohammed, Z ^a   Blankenstein, O ^b   De Lonlay, P ^c   Hussain, K ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

congenital hyperinsulinism; hyperinsulinaemic hypoglycaemia; insulinoma

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; 3 HYDROXYBUTYRIC ACID; 6 FLUORODOPA F 18; DIAZOXIDE; FATTY ACID; GLUCOKINASE; GLUCOSE; GLUTAMATE DEHYDROGENASE; GLUTAMATE DEHYDROGENASE 1; INSULIN; INSULIN RECEPTOR; OCTREOTIDE; SHORT CHAIN 3 HYDROXYACYL CO ENZYME A DEHYDROGENASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; BECKWITH WIEDEMANN SYNDROME; BLOOD GLUCOSE MONITORING; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONGENITAL DISORDER OF GLYCOSYLATION; DUMPING SYNDROME; EXERCISE INDUCED HYPERINSULINISM; FOLLOW UP; GAIN OF FUNCTION MUTATION; GENETIC DISORDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; HYPERINSULINEMIA HYPOGLYCEMIA; HYPERINSULINISM; HYPOGLYCEMIA; INSULIN AUTOIMMUNE SYNDROME; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULINOMA; INTRAUTERINE GROWTH RETARDATION; MATERNAL DIABETES MELLITUS; MITOCHONDRIAL RESPIRATION; NEWBORN PERIOD; NONINSULINOMA PANCREATOGENOUS HYPOGLYCEMIA SYNDROME; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PERINATAL ASPHYXIA; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; POSTPRANDIAL HYPERINSULINEMIC HYPOGLYCEMIA; PRIORITY JOURNAL; RHESUS ISOIMMUNIZATION; STOMACH BYPASS;

ANIMALS; HUMANS; HYPERINSULINISM; HYPOGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; POSTPRANDIAL PERIOD;

EID: 84895534234     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1367063     Document Type: Article

References (147)

1. Aynsley-Green A., Hussain K., Hall J., Saudubray J. M., Nihoul-Fekete C., De Lonlay-Debeney P., Brunelle F., Otonkoski T., Thornton P., Lindley K. J. Practical management of hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed: 2000; 82 F98 F107
2. Hussain K., Bryan J., Christesen H. T., Brusgaard K., Aguilar-Bryan L. Serum glucagon counterregulatory hormonal response to hypoglycemia is blunted in congenital hyperinsulinism. Diabetes: 2005; 54 2946 2951
3. Hussain K., Hindmarsh P., Aynsley-Green A. Neonates with symptomatic hyperinsulinemic hypoglycemia generate inappropriately low serum cortisol counterregulatory hormonal responses. J Clin Endocrinol Metab: 2003; 88 4342 4347
4. Kapoor R. R., Flanagan S. E., James C., Shield J., Ellard S., Hussain K. Hyperinsulinaemic hypoglycaemia. Arch Dis Child: 2009; 94 450 457
5. James C., Kapoor R. R., Ismail D., Hussain K. The genetic basis of congenital hyperinsulinism. J Med Genet: 2009; 46 289 299
6. Thomas P. M., Cote G. J., Wohllk N., Haddad B., Mathew P. M., Rabl W., Aguilar-Bryan L., Gagel R. F., Bryan J. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science: 1995; 268 426 429
7. Thomas P., Ye Y., Lightner E. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet: 1996; 5 1809 1812
8. Glaser B., Kesavan P., Heyman M., Davis E., Cuesta A., Buchs A., Stanley C. A., Thornton P. S., Permutt M. A., Matschinsky F. M., Herold K. C. Familial hyperinsulinism caused by an activating glucokinase mutation. New Engl J Med: 1998; 338 226 230
9. Clayton P. T., Eaton S., Aynsley-Green A., Edginton M., Hussain K., Krywawych S., Datta V., Malingre H. E., Berger R., van den Berg I. E. Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest: 2001; 108 457 465
10. Stanley C. A., Lieu Y. K., Hsu B. Y., Burlina A. B., Greenberg C. R., Hopwood N. J., Perlman K., Rich B. H., Zammarchi E., Poncz M. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. New Engl J Med: 1998; 338 1352 1357
11. Kapoor R. R., Flanagan S. E., Arya V. B., Shield J. P., Ellard S., Hussain K. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol: 2013; 168 557 564
12. Snider K. E., Becker S., Boyajian L., Shyng S. L., MacMullen C., Hughes N., Ganapathy K., Bhatti T., Stanley C. A., Ganguly A. Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. J Clin Endocrinol Metab: 2013; 98 E355 E363
13. Rahier J., Guiot Y., Sempoux C. Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Arch Dis Child Fetal Neonatal Ed: 2000; 82 F108 F112
14. Otonkoski T., Nanto-Salonen K., Seppanen M., Veijola R., Huopio H., Hussain K., Tapanainen P., Eskola O., Parkkola R., Ekstrom K., Guiot Y., Rahier J., Laakso M., Rintala R., Nuutila P., Minn H. Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. Diabetes: 2006; 55 13 18
15. Service F. J., Natt N., Thompson G. B., Grant C. S., van Heerden J. A., Andrews J. C., Lorenz E., Terzic A., Lloyd R. V. Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab: 1999; 84 1582 1589
16. Service G. J., Thompson G. B., Service F. J., Andrews J. C., Collazo-Clavell M. L., Lloyd R. V. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. New Engl J Med: 2005; 353 249 254
17. Patti M. E., McMahon G., Mun E. C., Bitton A., Holst J. J., Goldsmith J., Hanto D. W., Callery M., Arky R., Nose V., Bonner-Weir S., Goldfine A. B. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia: 2005; 48 2236 2240
18. Hojlund K., Hansen T., Lajer M., Henriksen J. E., Levin K., Lindholm J., Pedersen O., Beck-Nielsen H. A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene. Diabetes: 2004; 53 1592 1598
19. Dunne M. J., Cosgrove K. E., Shepherd R. M., Aynsley-Green A., Lindley K. J. Hyperinsulinism in infancy: from basic science to clinical disease. Physiol Rev: 2004; 84 239 275
20. Matschinsky F. M. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes: 1996; 45 223 241
21. Cryer P. E., Axelrod L., Grossman A. B., Heller S. R., Montori V. M., Seaquist E. R., Service F. J. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab: 2009; 94 709 728
22. Cryer P. E. Glucose counterregulation: prevention and correction of hypoglycemia in humans. Am J Physiol: 1993; 264 E149 E155
23. Malaisse W. J., Sener A., Herchuelz A., Hutton J. C. Insulin release: the fuel hypothesis. Metabolism: 1979; 28 373 386
24. Dunne M. J., Petersen O. H. Potassium selective ion channels in insulin-secreting cells: physiology, pharmacology and their role in stimulus-secretion coupling. Biochim Biophys Acta: 1991; 1071 67 82
25. Inagaki N., Gonoi T., Clement J. Pt, Namba N., Inazawa J., Gonzalez G., Aguilar-Bryan L., Seino S., Bryan J. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science: 1995; 270 1166 1170
26. Straub S. G., Cosgrove K. E., Ammala C., Shepherd R. M., O'Brien R. E., Barnes P. D., Kuchinski N., Chapman J. C., Schaeppi M., Glaser B., Lindley K. J., Sharp G. W., Aynsley-Green A., Dunne M. J. Hyperinsulinism of infancy: the regulated release of insulin by KATP channel-independent pathways. Diabetes: 2001; 50 329 339
27. Gembal M., Detimary P., Gilon P., Gao Z. Y., Henquin J. C. Mechanisms by which glucose can control insulin release independently from its action on adenosine triphosphate-sensitive K+ channels in mouse B cells. J Clin Invest: 1993; 91 871 880
28. Aizawa T., Sato Y., Ishihara F., Taguchi N., Komatsu M., Suzuki N., Hashizume K., Yamada T. ATP-sensitive K+ channel-independent glucose action in rat pancreatic beta-cell. Am J Physiol: 1994; 266 C622 C627
29. Ammala C., Eliasson L., Bokvist K., Berggren P. O., Honkanen R. E., Sjoholm A., Rorsman P. Activation of protein kinases and inhibition of protein phosphatases play a central role in the regulation of exocytosis in mouse pancreatic beta cells. Proc Natl Acad Sci USA: 1994; 91 4343 4347
30. Yajima H., Komatsu M., Schermerhorn T., Aizawa T., Kaneko T., Nagai M., Sharp G. W., Hashizume K. cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets. Diabetes: 1999; 48 1006 1012
31. Macfarlane W. M., Shepherd R. M., Cosgrove K. E., James R. F., Dunne M. J., Docherty K. Glucose modulation of insulin mRNA levels is dependent on transcription factor PDX-1 and occurs independently of changes in intracellular Ca2+. Diabetes: 2000; 49 418 423
32. Macfarlane W. M., McKinnon C. M., Felton-Edkins Z. A., Cragg H., James R. F., Docherty K. Glucose stimulates translocation of the homeodomain transcription factor PDX1 from the cytoplasm to the nucleus in pancreatic beta-cells. J Biol Chem: 1999; 274 1011 1016
33. Melloul D., Ben-Neriah Y., Cerasi E. Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters. Proc Natl Acad Sci USA: 1993; 90 3865 3869
34. Shepherd R. M., Cosgrove K. E., O'Brien R. E., Barnes P. D., Ammala C., Dunne M. J. Hyperinsulinism of infancy: towards an understanding of unregulated insulin release. European Network for Research into Hyperinsulinism in Infancy. Arch Dis Child Fetal Neonatal Ed: 2000; 82 F87 F97
35. Choufani S., Shuman C., Weksberg R. Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet: 2010; 154C 343 354
36. Kapoor R. R., Flanagan S. E., Fulton P., Chakrapani A., Chadefaux B., Ben-Omran T., Banerjee I., Shield J. P., Ellard S., Hussain K. Hyperinsulinism-hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype-phenotype correlations. Eur J Endocrinol: 2009; 161 731 735
37. Veit F., Heine R. G., Catto-Smith A. G. Dumping syndrome after Nissen fundoplication. J Paediatr Child Health: 1994; 30 182 185
38. Wiesli P., Schmid C., Perren A., Pfammatter T., Spinas G. A., Keller U. Hypoglycemia in response to glucose and glucagon in insulinoma patients with a negative prolonged fast: functional and morphological properties. J Endocrinol Invest: 2004; 27 832 838
39. Nestorowicz A., Wilson B. A., Schoor K. P., Inoue H., Glaser B., Landau H., Stanley C. A., Thornton P. S., Clement J. Pt, Bryan J., Aguilar-Bryan L., Permutt M. A. Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Hum Mol Genet: 1996; 5 1813 1822
40. Cartier E. A., Conti L. R., Vandenberg C. A., Shyng S. L. Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy. Proc Natl Acad Sci USA: 2001; 98 2882 2887
41. Partridge C. J., Beech D. J., Sivaprasadarao A. Identification and pharmacological correction of a membrane trafficking defect associated with a mutation in the sulfonylurea receptor causing familial hyperinsulinism. J Biol Chem: 2001; 276 35947 35952
42. Shyng S. L., Ferrigni T., Shepard J. B., Nestorowicz A., Glaser B., Permutt M. A., Nichols C. G. Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy. Diabetes: 1998; 47 1145 1151
43. Dunne M. J., Kane C., Shepherd R. M., Sanchez J. A., James R. F., Johnson P. R., Aynsley-Green A., Lu S., Clement J. Pt, Lindley K. J., Seino S., Aguilar-Bryan L. Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med: 1997; 336 703 706
44. Dekel B., Lubin D., Modan-Moses D., Quint J., Glaser B., Meyerovitch J. Compound heterozygosity for the common sulfonylurea receptor mutations can cause mild diazoxide-sensitive hyperinsulinism. Clin Pediatr (Phila): 2002; 41 183 186
45. Huopio H., Reimann F., Ashfield R., Komulainen J., Lenko H. L., Rahier J., Vauhkonen I., Kere J., Laakso M., Ashcroft F., Otonkoski T. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. J Clin Invest: 2000; 106 897 906
46. Pinney S. E., MacMullen C., Becker S., Lin Y. W., Hanna C., Thornton P., Ganguly A., Shyng S. L., Stanley C. A. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. J Clin Invest: 2008; 118 2877 2886
47. Kapoor R. R., Flanagan S. E., James C. T., McKiernan J., Thomas A. M., Harmer S. C., Shield J. P., Tinker A., Ellard S., Hussain K. Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations. Diabetologia: 2011; 54 2575 2583
48. Treberg J. R., Clow K. A., Greene K. A., Brosnan M. E., Brosnan J. T. Systemic activation of glutamate dehydrogenase increases renal ammoniagenesis: implications for the hyperinsulinism/hyperammonemia syndrome. Am J Physiol Endocrinol Metab: 2010; 298 E1219 E1225
49. MacMullen C., Fang J., Hsu B. Y., Kelly A., de Lonlay-Debeney P., Saudubray J. M., Ganguly A., Smith T. J., Stanley C. A. Hyperinsulinism/ hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate-binding domain of glutamate dehydrogenase. J Clin Endocrinol Metab: 2001; 86 1782 1787
50. Stanley C. A., Fang J., Kutyna K., Hsu B. Y., Ming J. E., Glaser B., Poncz M. Molecular basis and characterization of the hyperinsulinism/ hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA Contributing Investigators. Diabetes: 2000; 49 667 673
51. Palladino A. A., Stanley C. A. The hyperinsulinism/hyperammonemia syndrome. Rev Endocr Metab Disord: 2010; 11 171 178
52. Raizen D. M., Brooks-Kayal A., Steinkrauss L., Tennekoon G. I., Stanley C. A., Kelly A. Central nervous system hyperexcitability associated with glutamate dehydrogenase gain of function mutations. J Pediatr: 2005; 146 388 394
53. Kapoor R. R., Flanagan S. E., Fulton P., Chakrapani A., Chadefaux B., Ben-Omran T., Banerjee I., Shield J. P., Ellard S., Hussain K. Hyperinsulinism-hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype-phenotype correlations. Eur J Endocrinol: 2009; 161 731 735
54. Bahi-Buisson N., El Sabbagh S., Soufflet C., Escande F., Boddaert N., Valayannopoulos V., Bellane-Chantelot C., Lascelles K., Dulac O., Plouin P., de Lonlay P. Myoclonic absence epilepsy with photosensitivity and a gain of function mutation in glutamate dehydrogenase. Seizure: 2008; 17 658 664
55. Davis E. A., Cuesta-Munoz A., Raoul M., Buettger C., Sweet I., Moates M., Magnuson M. A., Matschinsky F. M. Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis. Diabetologia: 1999; 42 1175 1186
56. Cuesta-Munoz A. L., Huopio H., Otonkoski T., Gomez-Zumaquero J. M., Nanto-Salonen K., Rahier J., Lopez-Enriquez S., Garcia-Gimeno M. A., Sanz P., Soriguer F. C., Laakso M. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. Diabetes: 2004; 53 2164 2168
57. Christesen H. B., Jacobsen B. B., Odili S., Buettger C., Cuesta-Munoz A., Hansen T., Brusgaard K., Massa O., Magnuson M. A., Shiota C., Matschinsky F. M., Barbetti F. The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy. Diabetes: 2002; 51 1240 1246
58. Dullaart R. P., Hoogenberg K., Rouwe C. W., Stulp B. K. Family with autosomal dominant hyperinsulinism associated with A456V mutation in the glucokinase gene. J Intern Med: 2004; 255 143 145
59. Glaser B., Kesavan P., Heyman M., Davis E., Cuesta A., Buchs A., Stanley C. A., Thornton P. S., Permutt M. A., Matschinsky F. M., Herold K. C. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med: 1998; 338 226 230
60. Christesen H. B., Tribble N. D., Molven A., Siddiqui J., Sandal T., Brusgaard K., Ellard S., Njolstad P. R., Alm J., Brock Jacobsen B., Hussain K., Gloyn A. L. Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation. Eur J Endocrinol: 2008; 159 27 34
61. Sladek F. M., Zhong W. M., Lai E., Darnell J. E. Jr. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev: 1990; 4 2353 2365
62. Xanthopoulos K. G., Prezioso V. R., Chen W. S., Sladek F. M., Cortese R., Darnell J. E. Jr. The different tissue transcription patterns of genes for HNF-1, C/EBP, HNF-3, and HNF-4, protein factors that govern liver-specific transcription. Proc Natl Acad Sci USA: 1991; 88 3807 3811
63. Kuo C. J., Conley P. B., Chen L., Sladek F. M., Darnell J. E. Jr, Crabtree G. R. A transcriptional hierarchy involved in mammalian cell-type specification. Nature: 1992; 355 457 461
64. Kapoor R. R., Locke J., Colclough K., Wales J., Conn J. J., Hattersley A. T., Ellard S., Hussain K. Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations. Diabetes: 2008; 57 1659 1663
65. Pearson E. R., Boj S. F., Steele A. M., Barrett T., Stals K., Shield J. P., Ellard S., Ferrer J., Hattersley A. T. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med: 2007; 4 e118
66. Stanescu D. E., Hughes N., Kaplan B., Stanley C. A., De Leon D. D. Novel Presentations of Congenital Hyperinsulinism due to Mutations in the MODY genes: HNF1A and HNF4A. J Clin Endocrinol Metab: 2012; 97 E2026 E2030
67. Gupta R. K., Vatamaniuk M. Z., Lee C. S., Flaschen R. C., Fulmer J. T., Matschinsky F. M., Duncan S. A., Kaestner K. H. The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion. J Clin Invest: 2005; 115 1006 1015
68. Gremlich S., Nolan C., Roduit R., Burcelin R., Peyot M. L., Delghingaro-Augusto V., Desvergne B., Michalik L., Prentki M., Wahli W. Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor alpha transcriptional up-regulation of fatty acid oxidation. Endocrinology: 2005; 146 375 382
69. Hussain K., Clayton P. T., Krywawych S., Chatziandreou I., Mills P., Ginbey D. W., Geboers A. J., Berger R., van den Berg I. E., Eaton S. Hyperinsulinism of infancy associated with a novel splice site mutation in the SCHAD gene. J Pediatr: 2005; 146 706 708
70. Molven A., Matre G. E., Duran M., Wanders R. J., Rishaug U., Njolstad P. R., Jellum E., Sovik O. Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes: 2004; 53 221 227
71. Lantz K. A., Vatamaniuk M. Z., Brestelli J. E., Friedman J. R., Matschinsky F. M., Kaestner K. H. Foxa2 regulates multiple pathways of insulin secretion. J Clin Invest: 2004; 114 512 520
72. Sund N. J., Vatamaniuk M. Z., Casey M., Ang S. L., Magnuson M. A., Stoffers D. A., Matschinsky F. M., Kaestner K. H. Tissue-specific deletion of Foxa2 in pancreatic beta cells results in hyperinsulinemic hypoglycemia. Genes Dev: 2001; 15 1706 1715
73. Kapoor R. R., James C., Flanagan S. E., Ellard S., Eaton S., Hussain K. 3-Hydroxyacyl-coenzyme A dehydrogenase deficiency and hyperinsulinemic hypoglycemia: characterization of a novel mutation and severe dietary protein sensitivity. J Clin Endocrinol Metab: 2009; 94 2221 2225
74. Li C., Chen P., Palladino A., Narayan S., Russell L. K., Sayed S., Xiong G., Chen J., Stokes D., Butt Y. M., Jones P. M., Collins H. W., Cohen N. A., Cohen A. S., Nissim I., Smith T. J., Strauss A. W., Matschinsky F. M., Bennett M. J., Stanley C. A. Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase. J Biol Chem: 2010; 285 31806 31818
75. Heslegrave A. J., Kapoor R. R., Eaton S., Chadefaux B., Ackay T., Simsek E., Flanagan S. E., Ellard S., Hussain K. Leucine-sensitive hyperinsulinaemic hypoglycaemia in patients with loss of function mutations in 3-Hydroxyacyl-CoA Dehydrogenase. Orphanet J Rare Dis: 2012; 7 25
76. Flanagan S. E., Patch A. M., Locke J. M., Akcay T., Simsek E., Alaei M., Yekta Z., Desai M., Kapoor R. R., Hussain K., Ellard S. Genome-wide homozygosity analysis reveals HADH mutations as a common cause of diazoxide-responsive hyperinsulinemic-hypoglycemia in consanguineous pedigrees. J Clin Endocrinol Metab: 2011; 96 E498 E502
77. Otonkoski T., Kaminen N., Ustinov J., Lapatto R., Meissner T., Mayatepek E., Kere J., Sipila I. Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release. Diabetes: 2003; 52 199 204
78. Meissner T., Friedmann B., Okun J. G., Schwab M. A., Otonkoski T., Bauer T., Bartsch P., Mayatepek E. Massive insulin secretion in response to anaerobic exercise in exercise-induced hyperinsulinism. Horm Metab Res: 2005; 37 690 694
79. Ishihara H., Wang H., Drewes L. R., Wollheim C. B. Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in beta cells. J Clin Invest: 1999; 104 1621 1629
80. Service F. J., McMahon M. M., O'Brien P. C., Ballard D. J. Functioning insulinoma - incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc: 1991; 66 711 719
81. Kar P., Price P., Sawers S., Bhattacharya S., Reznek R. H., Grossman A. B. Insulinomas may present with normoglycemia after prolonged fasting but glucose-stimulated hypoglycemia. J Clin Endocrinol Metab: 2006; 91 4733 4736
82. Samuk I., Afriat R., Horne T., Bistritzer T., Barr J., Vinograd I. Dumping syndrome following Nissen fundoplication, diagnosis, and treatment. J Pediatr Gastroenterol Nutr: 1996; 23 235 240
83. Palladino A. A., Sayed S., Levitt Katz L. E., Gallagher P. R., De Leon D. D. Increased glucagon-like peptide-1 secretion and postprandial hypoglycemia in children after Nissen fundoplication. J Clin Endocrinol Metab: 2009; 94 39 44
84. Kneepkens C. M., Fernandes J., Vonk R. J. Dumping syndrome in children. Diagnosis and effect of glucomannan on glucose tolerance and absorption. Acta Paediatr Scand: 1988; 77 279 286
85. Basu A., Service F. J., Yu L., Heser D., Ferries L. M., Eisenbarth G. Insulin autoimmunity and hypoglycemia in seven white patients. Endocr Pract: 2005; 11 97 103
86. Lupsa B. C., Chong A. Y., Cochran E. K., Soos M. A., Semple R. K., Gorden P. Autoimmune forms of hypoglycemia. Medicine (Baltimore): 2009; 88 141 153
87. Marsk R., Jonas E., Rasmussen F., Naslund E. Nationwide cohort study of post-gastric bypass hypoglycaemia including 5 040 patients undergoing surgery for obesity in 1986-2006 in Sweden. Diabetologia: 2010; 53 2307 2311
88. Goldfine A. B., Mun E. C., Devine E., Bernier R., Baz-Hecht M., Jones D. B., Schneider B. E., Holst J. J., Patti M. E. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab: 2007; 92 4678 4685
89. Laferrere B., Heshka S., Wang K., Khan Y., McGinty J., Teixeira J., Hart A. B., Olivan B. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care: 2007; 30 1709 1716
90. Laferrere B., Teixeira J., McGinty J., Tran H., Egger J. R., Colarusso A., Kovack B., Bawa B., Koshy N., Lee H., Yapp K., Olivan B. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab: 2008; 93 2479 2485
91. Rabiee A., Magruder J. T., Salas-Carrillo R., Carlson O., Egan J. M., Askin F. B., Elahi D., Andersen D. K. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction. J Surg Res: 2011; 167 199 205
92. Perfetti R., Zhou J., Doyle M. E., Egan J. M. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology: 2000; 141 4600 4605
93. Drucker D. J. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol: 2003; 17 161 171
94. Rumilla K. M., Erickson L. A., Service F. J., Vella A., Thompson G. B., Grant C. S., Lloyd R. V. Hyperinsulinemic hypoglycemia with nesidioblastosis: histologic features and growth factor expression. Modern Pathol: 2009; 22 239 245
95. Won J. G., Tseng H. S., Yang A. H., Tang K. T., Jap T. S., Lee C. H., Lin H. D., Burcus N., Pittenger G., Vinik A. Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS). Clin Endocrinol (Oxf): 2006; 65 566 578
96. Verkarre V., Fournet J. C., de Lonlay P., Gross-Morand M. S., Devillers M., Rahier J., Brunelle F., Robert J. J., Nihoul-Fekete C., Saudubray J. M., Junien C. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest: 1998; 102 1286 1291
97. Fournet J. C., Mayaud C., de Lonlay P., Gross-Morand M. S., Verkarre V., Castanet M., Devillers M., Rahier J., Brunelle F., Robert J. J., Nihoul-Fekete C., Saudubray J. M., Junien C. Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11. Am J Pathol: 2001; 158 2177 2184
98. Ismail D., Smith V. V., de Lonlay P., Ribeiro M. J., Rahier J., Blankenstein O., Flanagan S. E., Bellanne-Chantelot C., Verkarre V., Aigrain Y., Pierro A., Ellard S., Hussain K. Familial focal congenital hyperinsulinism. J Clin Endocrinol Metab: 2011; 96 24 28
99. Finegold D. N., Stanley C. A., Baker L. Glycemic response to glucagon during fasting hypoglycemia: an aid in the diagnosis of hyperinsulinism. J Pediatr: 1980; 96 257 259
100. Levitt Katz L. E., Satin-Smith M. S., Collett-Solberg P., Thornton P. S., Baker L., Stanley C. A., Cohen P. Insulin-like growth factor binding protein-1 levels in the diagnosis of hypoglycemia caused by hyperinsulinism. J Pediatr: 1997; 131 193 199
101. Stanley C. A. Hyperinsulinism/hyperammonemia syndrome: insights into the regulatory role of glutamate dehydrogenase in ammonia metabolism. Mol Genet Metab: 2004; 81 01 S45 S51
102. Hsu B. Y., Kelly A., Thornton P. S., Greenberg C. R., Dilling L. A., Stanley C. A. Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr: 2001; 138 383 389
103. MacMullen C., Fang J., Hsu B. Y., Kelly A., de Lonlay-Debeney P., Saudubray J. M., Ganguly A., Smith T. J., Stanley C. A. Hyperinsulinism/ hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate-binding domain of glutamate dehydrogenase. J Clin Endocrinol Metab: 2001; 86 1782 1787
104. Service F. J., Natt N. The prolonged fast. J Clin Endocrinol Metab: 2000; 85 3973 3974
105. Touati G., Poggi-Travert F., Ogier de Baulny H., Rahier J., Brunelle F., Nihoul-Fekete C., Czernichow P., Saudubray J. M. Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria. Eur J Pediatr: 1998; 157 628 633
106. Grant D. B., Dunger D. B., Burns E. C. Long-term treatment with diazoxide in childhood hyperinsulinism. Acta Endocrinol Suppl (Copenh): 1986; 279 340 345
107. De Leon D. D., Stanley C. A. Mechanisms of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol Metab: 2007; 3 57 68
108. Laje P., Halaby L., Adzick N. S., Stanley C. A. Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism. Pediatr Diabetes: 2010; 11 142 147
109. Vezzosi D., Bennet A., Rochaix P., Courbon F., Selves J., Pradere B., Buscail L., Susini C., Caron P. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. Eur J Endocrinol: 2005; 152 757 767
110. Yorifuji T., Kawakita R., Hosokawa Y., Fujimaru R., Matsubara K., Aizu K., Suzuki S., Nagasaka H., Nishibori H., Masue M. Efficacy and safety of long-term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP-channel hyperinsulinism. Clin Endocrinol (Oxf): 2013; 78 891 897
111. Modan-Moses D., Koren I., Mazor-Aronovitch K., Pinhas-Hamiel O., Landau H. Treatment of congenital hyperinsulinism with lanreotide acetate (Somatuline Autogel). J Clin Endocrinol Metab: 2011; 96 2312 2317
112. Le Quan Sang K. H., Arnoux J. B., Mamoune A., Saint-Martin C., Bellanne-Chantelot C., Valayannopoulos V., Brassier A., Kayirangwa H., Barbier V., Broissand C., Fabreguettes J. R., Charron B., Thalabard J. C., de Lonlay P. Successful treatment of congenital hyperinsulinism with long-acting release octreotide. Eur J Endocrinol: 2012; 166 333 339
113. Mohnike K., Blankenstein O., Pfuetzner A., Potzsch S., Schober E., Steiner S., Hardy O. T., Grimberg A., van Waarde W. M. Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon. Horm Res: 2008; 70 59 64
114. De Leon D. D., Li C., Delson M. I., Matschinsky F. M., Stanley C. A., Stoffers D. A. Exendin-(9-39) corrects fasting hypoglycemia in SUR-1-/- mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion. J Biol Chem: 2008; 283 25786 25793
115. Calabria A. C., Li C., Gallagher P. R., Stanley C. A., De Leon D. D. GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channel. Diabetes: 2012; 61 2585 2591
116. Al-Shanafey S. Laparoscopic vs. open pancreatectomy for persistent hyperinsulinemic hypoglycemia of infancy. J Pediatr Surg: 2009; 44 957 961
117. Pierro A., Nah S. A. Surgical management of congenital hyperinsulinism of infancy. Semin Pediatr Surg: 2011; 20 50 53
118. Goossens A., Gepts W., Saudubray J. M., Bonnefont J. P., Nihoul F., Heitz P. U., Kloppel G. Diffuse and focal nesidioblastosis. A clinicopathological study of 24 patients with persistent neonatal hyperinsulinemic hypoglycemia. Am J Surg Pathol: 1989; 13 766 775
119. Rahier J., Guiot Y., Sempoux C. Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Arch Dis Child Fetal Neonat Ed: 2000; 82 F108 F112
120. Kloppel G., Reinecke-Luthge A., Koschoreck F. Focal and Diffuse Beta Cell Changes in Persistent Hyperinsulinemic Hypoglycemia of Infancy. Endocr Pathol: 1999; 10 299 304
121. Ismail D., Kapoor R. R., Smith V. V., Ashworth M., Blankenstein O., Pierro A., Flanagan S. E., Ellard S., Hussain K. The heterogeneity of focal forms of congenital hyperinsulinism. J Clin Endocrinol Metab: 2012; 97 E94 E99
122. Hardy O. T., Hernandez-Pampaloni M., Saffer J. R., Suchi M., Ruchelli E., Zhuang H., Ganguly A., Freifelder R., Adzick N. S., Alavi A., Stanley C. A. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan. J Pediatr: 2007; 150 140 145
123. Barthlen W., Blankenstein O., Mau H., Koch M., Hohne C., Mohnike W., Eberhard T., Fuechtner F., Lorenz-Depiereux B., Mohnike K. Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism. J Clin Endocrinol Metab: 2008; 93 869 875
124. Mohnike K., Blankenstein O., Christesen H. T., De Lonlay J., Hussain K., Koopmans K. P., Minn H., Mohnike W., Mutair A., Otonkoski T., Rahier J., Ribeiro M., Schoenle E., Fekete C. N. Proposal for a standardized protocol for 18F-DOPA-PET (PET/CT) in congenital hyperinsulinism. Horm Res: 2006; 66 40 42
125. Rahier J., Guiot Y., Sempoux C. Morphologic analysis of focal and diffuse forms of congenital hyperinsulinism. Semin Pediatr Surg: 2011; 20 3 12
126. Sempoux C., Capito C., Bellanne-Chantelot C., Verkarre V., de Lonlay P., Aigrain Y., Fekete C., Guiot Y., Rahier J. Morphological mosaicism of the pancreatic islets: a novel anatomopathological form of persistent hyperinsulinemic hypoglycemia of infancy. J Clin Endocrinol Metab: 2011; 96 3785 3793
127. Henquin J. C., Sempoux C., Marchandise J., Godecharles S., Guiot Y., Nenquin M., Rahier J. Congenital Hyperinsulinism Caused by Hexokinase I Expression or Glucokinase-Activating Mutation in a Subset of beta-Cells. Diabetes: 2013; 62 1689 1696
128. Beltrand J., Caquard M., Arnoux J. B., Laborde K., Velho G., Verkarre V., Rahier J., Brunelle F., Nihoul-Fekete C., Saudubray J. M., Robert J. J., de Lonlay P. Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism. Diabetes Care: 2012; 35 198 203
129. de Lonlay P., Fournet J. C., Rahier J., Gross-Morand M. S., Poggi-Travert F., Foussier V., Bonnefont J. P., Brusset M. C., Brunelle F., Robert J. J., Nihoul-Fekete C., Saudubray J. M., Junien C. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest: 1997; 100 802 807
130. Flanagan S. E., Xie W., Caswell R., Damhuis A., Vianey-Saban C., Akcay T., Darendeliler F., Bas F., Guven A., Siklar Z., Ocal G., Berberoglu M., Murphy N., O'Sullivan M., Green A., Clayton P. E., Banerjee I., Clayton P. T., Hussain K., Weedon M. N., Ellard S. Next-generation sequencing reveals deep intronic cryptic ABCC8 and HADH splicing founder mutations causing hyperinsulinism by pseudoexon activation. Am J Hum Genet: 2013; 92 131 136
131. Kapoor R. R., James C., Hussain K. Advances in the diagnosis and management of hyperinsulinemic hypoglycemia. Nat Clin Pract Endocrinol Metab: 2009; 5 101 112
132. Hardy O. T., Hernandez-Pampaloni M., Saffer J. R., Scheuermann J. S., Ernst L. M., Freifelder R., Zhuang H., MacMullen C., Becker S., Adzick N. S., Divgi C., Alavi A., Stanley C. A. Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism. J Clin Endocrinol Metab: 2007; 92 4706 4711
133. Laje P., States L. J., Zhuang H., Becker S. A., Palladino A. A., Stanley C. A., Adzick N. S. Accuracy of PET/CT Scan in the diagnosis of the focal form of congenital hyperinsulinism. J Pediatr Surg: 2013; 48 388 393
134. Meintjes M., Endozo R., Dickson J., Erlandsson K., Hussain K., Townsend C., Menezes L., Bomanji J. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective. Nucl Med Commun: 2013; 34 601 608
135. Ribeiro M. J., Boddaert N., Bellanne-Chantelot C., Bourgeois S., Valayannopoulos V., Delzescaux T., Jaubert F., Nihoul-Fekete C., Brunelle F., De Lonlay P. The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children. Eur J Nucl Med Mol Imaging: 2007; 34 2120 2128
136. Treglia G., Mirk P., Giordano A., Rufini V. Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: a meta-analysis. Pediatr Radiol: 2012; 42 1372 1379
137. Tseng L. M., Chen J. Y., Won J. G., Tseng H. S., Yang A. H., Wang S. E., Lee C. H. The role of intra-arterial calcium stimulation test with hepatic venous sampling (IACS) in the management of occult insulinomas. Ann Surg Oncol: 2007; 14 2121 2127
138. Brandle M., Pfammatter T., Spinas G. A., Lehmann R., Schmid C. Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours. Clin Endocrinol (Oxf): 2001; 55 357 362
139. Christ E., Wild D., Forrer F., Brandle M., Sahli R., Clerici T., Gloor B., Martius F., Maecke H., Reubi J. C. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. J Clin Endocrinol Metab: 2009; 94 4398 4405
140. Wild D., Macke H., Christ E., Gloor B., Reubi J. C. Glucagon-like peptide 1-receptor scans to localize occult insulinomas. New Engl J Med: 2008; 359 766 768
141. Kulke M. H., Bergsland E. K., Yao J. C. Glycemic control in patients with insulinoma treated with everolimus. New Engl J Med: 2009; 360 195 197
142. Fiebrich H. B., Siemerink E. J., Brouwers A. H., Links T. P., Remkes W. S., Hospers G. A., de Vries E. G. Everolimus induces rapid plasma glucose normalization in insulinoma patients by effects on tumor as well as normal tissues. Oncologist: 2011; 16 783 787
143. Leibiger I. B., Leibiger B., Moede T., Berggren P. O. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways. Mol Cell: 1998; 1 933 938
144. Aspinwall C. A., Lakey J. R., Kennedy R. T. Insulin-stimulated insulin secretion in single pancreatic beta cells. J Biol Chem: 1999; 274 6360 6365
145. Kellogg T. A., Bantle J. P., Leslie D. B., Redmond J. B., Slusarek B., Swan T., Buchwald H., Ikramuddin S. Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surg Obes Relat Dis: 2008; 4 492 499
146. Moreira R. O., Moreira R. B., Machado N. A., Goncalves T. B., Coutinho W. F. Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose. Obes Surg: 2008; 18 1618 1621
147. McLaughlin T., Peck M., Holst J., Deacon C. Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. The J Clin Endocrinol Metab: 2010; 95 1851 1855